SCHEMBL24508199

SCHEMBL24508199

CCCNOCCOCC(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 1/20 0.33
CES1 P23141 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21680742 0.81
SCHEMBL30218019 0.80 CA1 (0.32)
SCHEMBL1023903 0.78 CA1 (0.36)
SCHEMBL29069992 0.75
SCHEMBL29300034 0.73 CES1 (0.38) PLA2G2CCES1
SCHEMBL125933 0.73
SCHEMBL1591167 0.72 CA1 (0.35) CES1
SCHEMBL20079221 0.72 HTR1D (0.31) PLA2G2C
SCHEMBL3302738 0.71 ALDH1A1 (0.39) PLA2G2CCES1
SCHEMBL308836 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022125904-A1 ANTI-HER2 IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2022-06-16 WO disclosed